Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.362ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.362ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.362NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.265ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.265ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.265ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.265NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.585ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.585ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.585ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.585NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.351ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.351ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.351ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.351NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.243ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.243ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.243ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.243NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
R.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
R.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
R.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
R.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.216ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.216ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.216ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.216NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.471ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.471ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.471ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.471NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18639.2US
B.1.1.420ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.420ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.420ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.420NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
L.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
L.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
L.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used